ORGANOGENESIS HOLDINGS INC. Inventory, Finished Goods, Net of Reserves
ORGANOGENESIS HOLDINGS INC. (ORGO) had Inventory, Finished Goods, Net of Reserves of $15.31 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Inventory, Net, Items Net of Reserve Alternative › Inventory, Finished Goods and Work in Process, Net of Reserves
us-gaap:InventoryFinishedGoodsNetOfReserves · last filed 2026-08-06
- 2026-06-30: Inventory, Finished Goods, Net of Reserves $15.31M.
- 2026-03-31: Inventory, Finished Goods, Net of Reserves $12.94M.
- 2025-12-31: Inventory, Finished Goods, Net of Reserves $14.02M.
- 2025-09-30: Inventory, Finished Goods, Net of Reserves $24.37M.
| Period end | Inventory, Finished Goods, Net of Reserves |
|---|---|
| 2026-06-30 | $15.31M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $12.94M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $14.02M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $24.37M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $18.30M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $14.61M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $12.04M 10-K · filed 2026-02-26 |
| 2024-09-30 | $13.00M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $12.36M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $13.49M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $14.46M 10-K · filed 2025-02-27 |
| 2023-09-30 | $12.66M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $10.37M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $11.26M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $11.48M 10-K · filed 2024-02-29 |
| 2022-09-30 | $12.58M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $11.97M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $12.22M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $15.01M 10-K · filed 2023-03-01 |
| 2021-09-30 | $18.59M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $16.23M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $17.52M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $16.42M 10-K · filed 2022-03-01 |
| 2020-09-30 | $18.71M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $17.41M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $14.67M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $12.96M 10-K · filed 2021-03-16 |
| 2019-09-30 | $11.40M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $9.71M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $9.67M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $6.85M 10-K · filed 2020-03-09 |
| 2017-12-31 | $6.74M 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |